Blog: The Fine Print

Latest Watcher

by Matthew Madia, 2/22/2007

Safeguarding Public Health and the Environment, Cost-benefit Analysis, Industry Influence and Interference, Protecting Consumers, White House Influence and Interference, Government Performance
Be sure to check out the latest issue of our biweekly newsletter, The Watcher. Reg policy articles this time: Congress Holds Hearings on Bush's Changes to Regulatory Process FDA Drug Approval Process under Scrutiny
back to Blog
  • ©2025 Project On Government Oversight
  • All Rights Reserved.
  • This an archive site of the materials produced by the Center for Effective Government (formerly OMB Watch) and is maintained by the Project On Government Oversight.